2026 Summer Intern – Validation at Acadia Pharmaceuticals

Parsippany, New Jersey, United States

Acadia Pharmaceuticals Logo
Not SpecifiedCompensation
InternshipExperience Level
InternshipJob Type
UnknownVisa
BiopharmaceuticalIndustries

Requirements

  • Must be pursuing an engineering degree
  • Must be able to work onsite at the Parsippany, NJ office 5 days per week
  • Ability to complete the entire 10-week program (from May 26, 2026 to July 31, 2026) and commit to 37.5 hours per week
  • Cumulative 3.0 GPA or above; college transcript required (must mail official transcript by application deadline to specified address)
  • Currently enrolled in an accredited U.S. based college or university
  • Enrolled in either an undergraduate (Bachelor’s), graduate, MBA, JD, PharmD, or PhD program
  • Legally authorized to work in the U.S. without a need for sponsorship/CPT/OPT now or in the future
  • At least 18 years of age prior to the scheduled start date
  • Must be available to complete virtual interviews with HR and hiring manager
  • Must successfully pass a drug screen and background check prior to start date
  • Must complete a final presentation at the end of the 10-week program (mandatory)
  • Application deadline is January 9, 2026

Responsibilities

  • Support the execution of the pre and post verification of temperature / relative humidity valprobe data loggers used in the temperature mapping equipment
  • Support the execution of temperature mapping studies for refrigerators, incubators, freezers, stability chambers, warehouse
  • Support the execution of packaging engineering studies
  • Drafting engineering study reports and qualification summary reports
  • Assist in the preparation and execution commissioning/qualification study documentation

Skills

Key technologies and capabilities for this role

ValidationCommissioningQualificationTemperature MappingData LoggersPackaging EngineeringEngineering StudiesReport Drafting

Questions & Answers

Common questions about this position

Is this a remote position or does it require onsite work?

This is an onsite position requiring you to work at the Parsippany, NJ office 5 days per week.

What are the key requirements for this internship?

You must be pursuing an engineering degree, able to work onsite in Parsippany, NJ 5 days per week, and meet standard intern requirements including a 3.0 GPA, full 10-week commitment, and enrollment in an accredited U.S. college or university.

What is the duration and time commitment for the internship?

The program runs for 10 weeks from May 26, 2026 to July 31, 2026, requiring a commitment of 37.5 hours per week.

What is the application deadline and process for this internship?

The application deadline is January 9, 2026. You must mail an official college transcript by the deadline to Ferring Pharmaceuticals, Inc., Attn: Human Resources, Summer Intern Program, 100 Interpace Parkway, Parsippany, NJ 07054.

What does Ferring offer in terms of compensation and company recognition?

Ferring offers competitive total compensation along with an exceptional range of benefits. The company is recognized as one of 'The World’s Most Innovative Companies' by Fast Company, honored on Fortune’s 'Change the World List,' and Great Places to Work® Certified.

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters
1993Year Founded
$813.4MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Paid Vacation
Paid Holidays
Paid Sick Leave
Paid Parental Leave
Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.
Potential clinical trial delays could affect drug approval timelines.
Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
The company has a strong R&D foundation, developing innovative small molecule drugs.
Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI